Access to Megadoses of Vitamin D, Insufficient Knowledge of People and Poor Practice of Community Pharmacists, Made a Vicious Circle in the Direction to D Hypervitaminosis in Iran
Abstract
Access to Megadoses of Vitamin D, Insufficient Knowledge of People and Poor Practice of Community Pharmacists, Made a Vicious Circle in the Direction to D Hypervitaminosis in Iran.
1. Kulie T, Groff A, Redmer J, Hounshell J, Schrager S. Vitamin D: An Evidence-Based Review. J Am Board Fam Med. 2009;22(6):698-706.
2. Faghih S, Abdolahzadeh M, Mohammadi M, Hasanzadeh J. Prevalence of vitamin d deficiency and its related factors among university students in shiraz, iran. Int J Prev Med. 2014;5(6):796-9.
3. Tabrizi R, Moosazadeh M, Akbari M, et al. High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iran J Med Sci. 2018 Mar;43(2):125-139.
4. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18(2):153-165.
5. Najmabadi S, Nojomi M. Nutritional supplement use among adults in different areas of west Tehran. Iranian Journal of Endocrinology and Metabolism. 2010;12(4):365-75.
6. Mohammadnezhad G, Sattarpour M, Azadi Kakavand M, Esmaily H. Community Pharmacists’ Practice Regarding Vitamin D Products: A Simulated Client Method. Journal of Patient Safety & Quality Improvement. 2023;11(2):73-80.
7. Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004;4(1):1-6.
8. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005;135(2):310-6.
9. Hashemipour S, Ghobadi A, Hadizadeh Khairkhah SMR, et al. Association of weekly or biweekly use of 50 000 IU vitamin D3 with hypervitaminosis D. Brit J Clin Pharmacol. 2022;88(7):3506-9.
10. Esmaily H, Saffaei A. Vitamin D usage among Iranian population: A toxicity crisis is on the way. Oman Med J. 2019;34(2):174.
11. Jarusriwanna A, Phusunti S, Chotiyarnwong P, Unnanuntana A. High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial. BMC Geriatr. 2021;21(1):72.
12. Lanzi C, Missanelli A, Ieri A, et al. Vitamin D macro dosing in pregnancy: A case report of D hypervitaminosis in pregnancy according to non-conventional Coimbra protocol and perinatal toxicity. Neurotoxicology and Teratology. 2023;98:107221.
13. Lhamo Y, Chugh PK, Gautam SR, Tripathi C. Epidemic of Vitamin D deficiency and its management: awareness among indian medical undergraduates. J Environ Public Health. 2017;2017 :2517207.
2. Faghih S, Abdolahzadeh M, Mohammadi M, Hasanzadeh J. Prevalence of vitamin d deficiency and its related factors among university students in shiraz, iran. Int J Prev Med. 2014;5(6):796-9.
3. Tabrizi R, Moosazadeh M, Akbari M, et al. High prevalence of vitamin D deficiency among Iranian population: a systematic review and meta-analysis. Iran J Med Sci. 2018 Mar;43(2):125-139.
4. Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18(2):153-165.
5. Najmabadi S, Nojomi M. Nutritional supplement use among adults in different areas of west Tehran. Iranian Journal of Endocrinology and Metabolism. 2010;12(4):365-75.
6. Mohammadnezhad G, Sattarpour M, Azadi Kakavand M, Esmaily H. Community Pharmacists’ Practice Regarding Vitamin D Products: A Simulated Client Method. Journal of Patient Safety & Quality Improvement. 2023;11(2):73-80.
7. Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004;4(1):1-6.
8. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005;135(2):310-6.
9. Hashemipour S, Ghobadi A, Hadizadeh Khairkhah SMR, et al. Association of weekly or biweekly use of 50 000 IU vitamin D3 with hypervitaminosis D. Brit J Clin Pharmacol. 2022;88(7):3506-9.
10. Esmaily H, Saffaei A. Vitamin D usage among Iranian population: A toxicity crisis is on the way. Oman Med J. 2019;34(2):174.
11. Jarusriwanna A, Phusunti S, Chotiyarnwong P, Unnanuntana A. High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial. BMC Geriatr. 2021;21(1):72.
12. Lanzi C, Missanelli A, Ieri A, et al. Vitamin D macro dosing in pregnancy: A case report of D hypervitaminosis in pregnancy according to non-conventional Coimbra protocol and perinatal toxicity. Neurotoxicology and Teratology. 2023;98:107221.
13. Lhamo Y, Chugh PK, Gautam SR, Tripathi C. Epidemic of Vitamin D deficiency and its management: awareness among indian medical undergraduates. J Environ Public Health. 2017;2017 :2517207.
| Files | ||
| Issue | Vol 11, No 3 (Summer 2023) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/jpc.v11i3.15994 | |
| Keywords | ||
| Megadose VitaminD Community Pharmacists Hypervitaminosis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Mohammad Soleymani S, Esmaily H. Access to Megadoses of Vitamin D, Insufficient Knowledge of People and Poor Practice of Community Pharmacists, Made a Vicious Circle in the Direction to D Hypervitaminosis in Iran. J Pharm Care. 2023;11(3):124-125.
